After logging a whopping 42% sales growth in 2015 thanks to the $50 billion merger with Covidien, Medtronic saw just a 1% uptick in sales from 2015 to 2016.
Edwards Lifesciences has penned a deal to buy Valtech Cardio for up to $690 million, less than the heart valve company looked set to be acquired for last year.
HeartWare was hit with a Class I recall for its ventricular assist device pumps, adding to its laundry list of woes months after Medtronic acquired the company.
